The American Medical Association (AMA) has advocated for insurance companies and federal payers to fully cover new obesity treatments, such as Wegovy and Ozempic, despite their high costs. The AMA recognises obesity as a significant health concern and has passed a resolution supporting health insurance coverage for FDA-approved obesity treatments. Medicare currently doesn’t cover weight-loss drugs, and private insurers often view such treatments as non-essential, but change may be on the horizon.
Prinz Eugen Ransomware Uses Go-Based Encryptor to Target Fresh Files and Evade Forensics
A customer compromised by a newly observed ransomware family we attribute to the Prinz Eugen group. The encryptor is a purpose-built Go binary that departs
